Financhill
Back

Biomerica 10K Form

Sell
39

BMRA
Biomerica

Last Price:
$0.33
Seasonality Move:
9.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive BMRA News And Ratings

See the #1 stock for the next 7 days that we like better than BMRA

BMRA Financial Statistics

Sales & Book Value

Annual Sales: $5.4M
Cash Flow: $-1.3M
Price / Cash Flow: 0
Annual Sales: $0.32
Price / Book: 1.01

Profitability

EPS (TTM): -0.37000
Net Income (TTM): $-6.2M
Gross Margin: $611K
Return on Equity: -77.23%
Return on Assets: -58.67%

Biomerica Earnings Forecast

Key Biomerica Financial Ratios

  • The Gross Profit Margin over the past 41 years for BMRA is 11.28%.
  • The Selling, General & Administrative Expenses for BMRA have been equal to 101.33% of Gross Profit Margin.
  • The Research & Development expenses have been 27.53% of Revenue.
  • The Net Earning history of BMRA is -110.40% of Total Revenues.
  • Per Share Earnings over the last 41 years have been positive in 20 years.

Biomerica Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: BMRA
CUSIP: 09061H
Website: biomerica.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3
Quick Ratio: 2.03

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BMRA Technical Analysis vs Fundamental Analysis

Sell
39
Biomerica (BMRA) is a Sell

Is Biomerica a Buy or a Sell?

  • Biomerica stock is rated a Sell
    The current Biomerica [BMRA] share price is $0.32. The Score for BMRA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.